Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Acetate Ringer’s solution + glucose is an intravenous fluid formulation combining an electrolyte-balanced acetate-based crystalloid (acetate Ringer’s) with added glucose (commonly 1% or 5%). The base solution contains sodium chloride, potassium chloride, calcium chloride, magnesium chloride (in some formulations), and sodium acetate as the buffer. The addition of glucose provides a source of energy and can help prevent catabolism during illness or surgery. This combination is used for extracellular fluid replacement in settings such as dehydration, diarrhea in calves and children, perioperative care (including neurosurgery), and maintenance infusions. It helps restore plasma volume and correct acid-base imbalances while providing metabolic substrate to reduce endogenous fat mobilization[1][2][4][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on acetate Ringer's solution + glucose.